These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32224420)

  • 1. Evaluation of nicotine patch adherence measurement using self-report and saliva cotinine among abstainers in a smoking cessation trial.
    Schnoll R; Paul Wileyto E; Gross R; Hitsman B; Hawk LW; Cinciripini P; George TP; Benowitz NL; Fen Lubitz S; Ashare R; Tyndale RF; Lerman C
    Drug Alcohol Depend; 2020 May; 210():107967. PubMed ID: 32224420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches.
    Claire R; Coleman T; Leonardi-Bee J; Berlin I
    Addiction; 2019 Sep; 114(9):1651-1658. PubMed ID: 31106486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term nicotine substitution after application of a 16-hour nicotine patch in smoking cessation.
    Nørregaard J; Tønnesen P; Simonsen K; Säwe U
    Eur J Clin Pharmacol; 1992; 43(1):57-60. PubMed ID: 1505610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures and predictors of varenicline adherence in the treatment of nicotine dependence.
    Peng AR; Morales M; Wileyto EP; Hawk LW; Cinciripini P; George TP; Benowitz NL; Nollen NL; Lerman C; Tyndale RF; Schnoll R
    Addict Behav; 2017 Dec; 75():122-129. PubMed ID: 28728040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of saliva cotinine and exhaled carbon monoxide concentrations when smoking and after being offered dual nicotine replacement therapy in pregnancy.
    Slaich B; Claire R; Emery J; Lewis S; Cooper S; Thomson R; Phillips L; Kinahan-Goodwin D; Naughton F; McDaid L; Clark M; Dickinson A; Coleman T
    Addiction; 2022 Mar; 117(3):751-759. PubMed ID: 34427009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels.
    Fredrickson PA; Hurt RD; Lee GM; Wingender L; Croghan IT; Lauger G; Gomez-Dahl L; Offord KP
    Psychopharmacology (Berl); 1995 Dec; 122(3):215-22. PubMed ID: 8748390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of adherence to nicotine replacement therapy: Machine learning evidence that perceived need predicts medication use.
    Kim N; McCarthy DE; Loh WY; Cook JW; Piper ME; Schlam TR; Baker TB
    Drug Alcohol Depend; 2019 Dec; 205():107668. PubMed ID: 31707266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine Metabolism-informed Care for Smoking Cessation: A Pilot Precision RCT.
    Wells QS; Freiberg MS; Greevy RA; Tyndale RF; Kundu S; Duncan MS; King S; Abney L; Scoville E; Beaulieu DB; Gatskie V; Tindle HA
    Nicotine Tob Res; 2018 Nov; 20(12):1489-1496. PubMed ID: 29059367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes.
    Peng AR; Schnoll R; Hawk LW; Cinciripini P; George TP; Lerman C; Tyndale RF
    Drug Alcohol Depend; 2018 Sep; 190():72-81. PubMed ID: 29986268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we increase smokers' adherence to nicotine replacement therapy and does this help them quit?
    Schlam TR; Cook JW; Baker TB; Hayes-Birchler T; Bolt DM; Smith SS; Fiore MC; Piper ME
    Psychopharmacology (Berl); 2018 Jul; 235(7):2065-2075. PubMed ID: 29696311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study.
    Schnoll RA; Patterson F; Wileyto EP; Tyndale RF; Benowitz N; Lerman C
    Pharmacol Biochem Behav; 2009 Mar; 92(1):6-11. PubMed ID: 19000709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
    Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of Self-Reported Tobacco Smoke Exposure among Non-Smoking Adult Public Housing Residents.
    Fang SC; Chen S; Trachtenberg F; Rokicki S; Adamkiewicz G; Levy DE
    PLoS One; 2016; 11(5):e0155024. PubMed ID: 27171392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation.
    Schnoll RA; Wileyto EP; Lerman C
    Addict Behav; 2012 Apr; 37(4):565-8. PubMed ID: 22244706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in saliva cotinine as a function of self-reported attempts to reduce cigarette consumption.
    Fidler JA; Stapleton JA; West R
    Psychopharmacology (Berl); 2011 Oct; 217(4):587-93. PubMed ID: 21556806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting smoking cessation. Who will quit with and without the nicotine patch.
    Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
    JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating nondepressed smokers with alcohol dependence in sustained full remission: nicotine patch therapy tailored to baseline serum cotinine.
    Hurt RD; Patten CA; Offord KP; Croghan IT; Decker PA; Morris RA; Hays JT
    J Stud Alcohol; 2005 Jul; 66(4):506-16. PubMed ID: 16240558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline and Nicotine Patch Therapies in Young Adults Motivated to Quit Smoking: A Randomized, Placebo-controlled, Prospective Study.
    Tuisku A; Salmela M; Nieminen P; Toljamo T
    Basic Clin Pharmacol Toxicol; 2016 Jul; 119(1):78-84. PubMed ID: 26709238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive nicotine patch dosing prior to quitting smoking: feasibility, safety and effects during the pre-quit and post-quit periods.
    Przulj D; Wehbe L; McRobbie H; Hajek P
    Addiction; 2019 Mar; 114(3):515-522. PubMed ID: 30370685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.